Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease.

Saved in:
Bibliographic Details
Title: Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease.
Authors: Foot JS; Pharmaxis Ltd., 20 Rodborough Road, Frenchs Forest, NSW 2086, Australia. Electronic address: jonathan.foot@pharmaxis.com.au., Buson A; Pharmaxis Ltd., 20 Rodborough Road, Frenchs Forest, NSW 2086, Australia., Deodhar M; Pharmaxis Ltd., 20 Rodborough Road, Frenchs Forest, NSW 2086, Australia., Findlay AD; Pharmaxis Ltd., 20 Rodborough Road, Frenchs Forest, NSW 2086, Australia., Robertson AD; Pharmaxis Ltd., 20 Rodborough Road, Frenchs Forest, NSW 2086, Australia., Turner CI; Pharmaxis Ltd., 20 Rodborough Road, Frenchs Forest, NSW 2086, Australia., Yow T; Pharmaxis Ltd., 20 Rodborough Road, Frenchs Forest, NSW 2086, Australia., Zhou W; Pharmaxis Ltd., 20 Rodborough Road, Frenchs Forest, NSW 2086, Australia., Jarolimek W; Pharmaxis Ltd., 20 Rodborough Road, Frenchs Forest, NSW 2086, Australia.
Source: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2022 Oct 15; Vol. 74, pp. 128942. Date of Electronic Publication: 2022 Aug 13.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3405 (Electronic) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1464-3405
DOI:10.1016/j.bmcl.2022.128942